Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -705 | -2,419 | -1,933 | -1,229 | -615 |
| Depreciation Amortization | 38 | 162 | 126 | 84 | 42 |
| Accounts receivable | 265 | -400 | -26 | N/A | -65 |
| Other Working Capital | 613 | -307 | -92 | -264 | -220 |
| Other Operating Activity | -266 | 895 | 402 | 286 | 260 |
| Operating Cash Flow | $-55 | $-2,069 | $-1,523 | $-1,123 | $-598 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -37 | -5 | -2 | N/A | -4 |
| Purchase Of Investment | 1 | 6 | N/A | N/A | N/A |
| Investing Cash Flow | $-36 | $1 | $-2 | $N/A | $-4 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -46 | -5 | -45 | -37 |
| Common Stock Issued | 3,662 | 2,206 | 2,278 | 1,892 | 1,853 |
| Financing Cash Flow | $3,662 | $2,160 | $2,273 | $1,847 | $1,816 |
| Beginning Cash Position | 93 | 1 | 1 | 1 | 1 |
| End Cash Position | 3,664 | 93 | 749 | 725 | 1,215 |
| Net Cash Flow | $3,571 | $92 | $748 | $724 | $1,214 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55 | -2,069 | -1,523 | -1,123 | -598 |
| Capital Expenditure | -37 | -5 | -2 | N/A | -4 |
| Free Cash Flow | -92 | -2,074 | -1,525 | -1,123 | -602 |